Takeda, Frazier Healthcare collaborate to launch Phathom Pharmaceuticals

This article was originally published here

Takeda has granted a license to Phathom for the development and exclusive commercialization rights to vonoprazan in the United States, Europe and Canada in exchange for upfront cash

The post Takeda, Frazier Healthcare collaborate to launch Phathom Pharmaceuticals appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply